The Health Ministry has advised states to organise vaccination sessions taking into account 10 per cent reserve or wastage doses and an average of 100 vaccinations...
Covishield and Covaxin, the two COVID-19 vaccines, which have received Emergency Use Authorisation (EAU) in India
According to the recently published study, SARS-CoV-2 may resemble the mild cold-causing coronaviruses
Touted to be the world's biggest vaccination drive against the coronavirus has been set in motion. India begins inoculation on January 16; healthcare workers and frontline...
Delhi Police formed a green corridor to safely transport the COVID-19 vaccine from airport to the hospital, the Delhi government's largest COVID-19 facility
Covishield is developed by Oxford University and British-Swedish company AstraZeneca and manufactured by the Serum Institute of India
The first phase of the COVID-19 vaccination drive in India will begin from January 16 with 30 crore people in the priority group
The share of active cases in the total positive cases has further compressed to 2.07 per cent of the cumulative caseload, stated the Ministry of Health...
India will receive 1.1 crore COVID-19 vaccine doses from the Serum Institute of India and 55 lakh from Bharat Biotech by January 14
Though the mutant strains of the Coronavirus tend to spread faster and be more infectious, they do not seem to cause more severe illness or a...
Scientists typically estimate that a vaccination rate of about 70 per cent is needed for herd immunity, where entire populations are protected against a disease
The COVID-19 vaccine Sputnik V's efficacy is confirmed at 91.4 per cent based on data analysis of the final control point of clinical trials in Russia